Pharmaceutical

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity

Bicara was one of three biotechs that went public last week in one of the busiest biotech IPO windows this year.

Sep 18, 2024 - 04:00
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity
Bicara was one of three biotechs that went public last week in one of the busiest biotech IPO windows this year.
Read the original article

Tags:

Previous Article

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy

Next Article

Podcast: How drones are transforming the clinical supply chain in Africa

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Nearly half of U.S. adults would spend $100 a month for weight loss drugs; Pfizer scraps an obesity pill

STAT+: Pharmalittle: Nearly half of U.S. adults would s...

Jun 26, 2023

STAT+: Eli Lilly’s chief scientist on new obesity drug data, gene editing, and a potential new heart drug

STAT+: Eli Lilly’s chief scientist on new obesity drug ...

Nov 13, 2023

Generative AI – beyond the hype

Generative AI – beyond the hype

Jul 3, 2023